Medidata
Medidata Solutions, Inc., headquartered in the United States, is a leading player in the life sciences industry, specialising in cloud-based solutions for clinical trials. Founded in 1999, the company has achieved significant milestones, including the development of innovative technologies that streamline the drug development process. With a strong presence in North America, Europe, and Asia, Medidata offers a comprehensive suite of products and services, including data management, analytics, and patient engagement tools. Their unique platform integrates advanced analytics and artificial intelligence, enabling biopharmaceutical companies to enhance decision-making and improve trial outcomes. Recognised for its market leadership, Medidata has been instrumental in transforming clinical research, supporting over 25,000 trials and 5 million patients globally. The company’s commitment to innovation and excellence positions it as a trusted partner in the evolving landscape of clinical development.
DitchCarbon Score
How does Medidata's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medidata's score of 24 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medidata's reported carbon emissions
In 2019, Medidata reported total carbon emissions of approximately 15,014,000 kg CO2e, comprising 242,160 kg CO2e from Scope 1, 1,834,440 kg CO2e from Scope 2, and about 13,937,400 kg CO2e from Scope 3 emissions. The Scope 3 emissions were significantly driven by business travel (15,014,000 kg CO2e) and employee commuting (9,747,000 kg CO2e), highlighting the impact of operational activities on their overall carbon footprint. While specific reduction targets or commitments were not disclosed, Medidata's emissions data indicates a focus on understanding and managing their carbon impact across all scopes. The company has not yet established formal science-based targets or climate pledges, which are essential for aligning with global climate goals. Overall, Medidata's emissions profile reflects the challenges faced by organisations in the tech sector, particularly in managing Scope 3 emissions, which often represent the largest portion of total emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2017 | 2018 | 2019 | |
|---|---|---|---|
| Scope 1 | - | 000,000 | 000,000 |
| Scope 2 | 1,831,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 6,330,040 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medidata is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
